ConductScience.org, home

Paper201618

Purification and properties of the two major isozymes of alpha-galactosidase from human placenta.

Kusiak JW and 2 others. J Biol Chem, 1978. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Purification and properties of the two major isozymes of alpha-galactosidase from human placenta. Papers, record 201618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/201618

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Purification and properties of the two major isozymes of alpha-galactosidase from human placenta.
PubMed
Journal
J Biol Chem
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.71
iCite
Revised in PubMed
2021-02-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kusiak JWJ W
2Quirk JMJ M
3Brady ROR O

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GalactosidasesMajor topic
IsoenzymesMajor topic
PlacentaMajor topic
alpha-GalactosidaseMajor topic
Female
Humans
Kinetics
Methods
Molecular Weight
Pregnancy

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
40725422Comparative Evaluation of AAV8 and AAV9 Gene Therapy in Fabry Knockout (Gla-/y) and Symptomatic (G3STg/+Gla-/y) Murine Models.Genes (Basel)2025https://conductscience.org/library/papers/40725422PubMed
36959353Optimizing human α-galactosidase for treatment of Fabry disease.Sci Rep2023https://conductscience.org/library/papers/36959353PubMed
33809185Intra-Laboratory Validation of Alpha-Galactosidase Activity Measurement in Dietary Supplements.Molecules2021https://conductscience.org/library/papers/33809185PubMed
32995357In Vitro and In Vivo Amenability to Migalastat in Fabry Disease.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/32995357PubMed
30038331Urine-derived cells: a promising diagnostic tool in Fabry disease patients.Sci Rep2018https://conductscience.org/library/papers/30038331PubMed
28545388Chemical and structural characterization of α-N-acetylgalactosaminidase I and II from starfish, asterina amurensis.BMC Biochem2017https://conductscience.org/library/papers/28545388PubMed
25719393Carboxyl-terminal truncations alter the activity of the human α-galactosidase A.PLoS One2015https://conductscience.org/library/papers/25719393PubMed
23691056Dysregulated autophagy contributes to podocyte damage in Fabry's disease.PLoS One2013https://conductscience.org/library/papers/23691056PubMed
23118528Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy.Drug Des Devel Ther2012https://conductscience.org/library/papers/23118528PubMed
21747096Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice.J Lipid Res2011https://conductscience.org/library/papers/21747096PubMed
20526001Use of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase A in intact cells.J Lipid Res2010https://conductscience.org/library/papers/20526001PubMed
20398385Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transfer.J Biomed Sci2010https://conductscience.org/library/papers/20398385PubMed
20385825Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20385825PubMed
18698230Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone.Pharmacogenet Genomics2008https://conductscience.org/library/papers/18698230PubMed
17644384Establishment and characterization of Fabry disease endothelial cells with an extended lifespan.Mol Genet Metab2007https://conductscience.org/library/papers/17644384PubMed
17532296Screening for pharmacological chaperones in Fabry disease.Biochem Biophys Res Commun2007https://conductscience.org/library/papers/17532296PubMed
17188539Cellular and tissue distribution of intravenously administered agalsidase alfa.Mol Genet Metab2007https://conductscience.org/library/papers/17188539PubMed
17105746Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.Brain2007https://conductscience.org/library/papers/17105746PubMed
16347214Production, Purification, and Characterization of alpha-Galactosidase from Monascus pilosus.Appl Environ Microbiol1986https://conductscience.org/library/papers/16347214PubMed
16151903High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease.J Inherit Metab Dis2005https://conductscience.org/library/papers/16151903PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/201618

GET https://conductscience.org/api/papers/v1/201618/cited_by?page=2